According to Abeona Therapeutics 's latest financial reports the company's current EPS (TTM) is -$3.00. In 2022 the company made an earnings per share (EPS) of -$6.70 an increase over its 2021 EPS that were of -$21.23.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.00 | -55.19% |
2022 | -$6.70 | -68.42% |
2021 | -$21.23 | -6.68% |
2020 | -$22.75 | -40.13% |
2019 | -$38.00 | 28.81% |
2018 | -$29.50 | 78.79% |
2017 | -$16.50 | 3.13% |
2016 | -$16.00 | 25.49% |
2015 | -$12.75 | -98.31% |
2014 | -$752.59 | -1043.69% |
2013 | $79.75 | -112.27% |
2012 | -$650.00 | 136.36% |
2011 | -$275.00 | -61.4% |
2010 | -$712.50 | -64.81% |
2009 | -$2,025 | -54.24% |
2008 | -$4,425 | -65.73% |
2007 | -$12,912 | 183.35% |
2006 | -$4,557 | 587.86% |
2005 | -$662.50 | -84.55% |
2004 | -$4,288 | 28.95% |
2003 | -$3,325 | -26.11% |
2002 | -$4,500 | 53.19% |
2001 | -$2,938 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Merck MRK | $1.82 | -160.65% | ๐บ๐ธ USA |
Taro Pharmaceutical TARO | $0.61 | -120.31% | ๐ฎ๐ฑ Israel |